Long term treatment of hypercholesterolemia with simvastatin (1990)
- Autores:
- Autores USP: BERNIK, MARCIA MARTINS SILVEIRA - HU ; QUINTAO, EDER CARLOS ROCHA - FM
- Unidades: HU; FM
- Assunto: ENDOCRINOLOGIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Anais
- Nome do evento: Congresso Panamericano de Endocrinologia
-
ABNT
NAKANDAKARE, E et al. Long term treatment of hypercholesterolemia with simvastatin. 1990, Anais.. Recife: Hospital Universitário, Universidade de São Paulo, 1990. . Acesso em: 26 abr. 2024. -
APA
Nakandakare, E., Bernik, M. M. S., Neves, M. Q. T. S., Giglio, C. C., Catanozi, S., & Quintão, E. C. da R. (1990). Long term treatment of hypercholesterolemia with simvastatin. In Anais. Recife: Hospital Universitário, Universidade de São Paulo. -
NLM
Nakandakare E, Bernik MMS, Neves MQTS, Giglio CC, Catanozi S, Quintão EC da R. Long term treatment of hypercholesterolemia with simvastatin. Anais. 1990 ;[citado 2024 abr. 26 ] -
Vancouver
Nakandakare E, Bernik MMS, Neves MQTS, Giglio CC, Catanozi S, Quintão EC da R. Long term treatment of hypercholesterolemia with simvastatin. Anais. 1990 ;[citado 2024 abr. 26 ] - Plasma cholesterol and CETP concentrations are lowered by dietary phytosterol ester but only the cholesterol variation related to the CETP 1405V polymorphism
- Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Artificial chylomicrons metabolism as a probe for the plasma lipid lowering drug action mechanism
- Disturbances of lipid metabolism in hypothyroidism studied by artificial chylomicrons
- Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia
- Ldl-apheresis in the treatment of one patient with homozygous familial hypercholesterolemia
- Fitoesterol esterificado na dieta diminui a concentração plasmática de colesterol e de CETP relacionada ao polimorfismo 1405V da CETP
- Eficiencia dos esteres de fitoesterois alimentares na reducao dos lipides plasmaticos em hipercolesterolemicos moderados
- The age-related rise of plasma cholesterol in humans is not caused by a cell removal defect of LDL particles: 'in vitro' studies in peripheral mononuclear blood cells
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
